Men diagnosed at this hospital trust can access the following services:

• Diagnostic Facilities:
• Multiparametric MRI
• Transperineal biopsy under local anaesthetic
• Transperineal biopsy under general anaesthetic
• Transrectal ultrasound (TRUS) biopsy
• PSMA (prostate-specific membrane antigen) PET scan
• Isotope bone scan

• Treatment Facilities:
• Radical prostatectomy
• Robot assisted laparoscopic prostatectomy
• External beam radiotherapy (EBRT)
• High-dose rate brachytherapy
• Chemotherapy
• Joint specialist MDT clinic

• Support Service Facilities:
• Clinical Nurse Specialist (CNS) in all clinics
• Prostate cancer-specific CNSs
• Advanced PCa CNS
• Urology CNS
• Sexual function services
• Specialist continence services
• Psychological counselling

	Diagnosing Trust	Specialist MDT
No. of Cancer Registry records	207	814
Performance Status recorded	98%	92%
PSA completed	99%	84%
Gleason Score completed	N/A	N/A
TNM completed	75%	63%
Stage variable assigned	96%	87%

	Specialist MDT	National
No. of men with disease status determined	724	23477
Percentage of men diagnosed with metastatic disease	16%	17%
No. of men diagnosed with M1 (metastases)	116	N/A

These indicators could not be reported this year for England as we were unable to assign a patient to a particular risk group due to the unavailability of information on Gleason score in the Rapid Cancer Registration Dataset

	Treatment Centre
No. of men who received radical prostatectomy (2020-2021)	148
Adjusted percentage of men who had an emergency readmission within 90 days of radical prostatectomy (%)	17%
No. of men who received radical prostatectomy (2019)	145
Adjusted percentage of men experiencing at least one GU complication (%)	10%
No. of men who received radical radiotherapy (2019)	116
Adjusted percentage of men experiencing at least one GI complication (%)	11%